Michael Schwendinger
9Patents
3h-index
17Co-inventors
54Inventor score
Filing activity: Mar 25, 1999 → Apr 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6291239A | Monoclonal antibody | Chemistry; Metallurgy | 16 | Expired |
| US11305000B2 | Chimeric OspA genes, proteins and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US10669315B2 | HPV vaccines | Emerging Cross-Sectional Technologies | 6 | Active |
| US8623376B2 | Chimeric OspA genes, proteins, and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11407790B2 | HPV vaccines | Emerging Cross-Sectional Technologies | 1 | Active |
| US8623375B2 | Chimeric OspA genes, proteins, and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9303073B2 | Chimeric OspA proteins and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9334311B2 | Chimeric OspA genes, proteins and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9895434B2 | Chimeric OspA genes, proteins and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.